Backlinks
| Referring page | DR | Ref. domains | Linked domains | Anchor and target URL |
|---|---|---|---|---|
|
The Benefits of Implementing Digitized SoA in Clinical Research Protocols - A...
https://www.astrixinc.com/blog/the-benefits-of-implementing-digitized-soa-in-clinical-research-protocols
astrixinc.com
|
15 | 18 | 146 |
https://csdd.tufts.edu/impact-reports
https://csdd.tufts.edu/impact-reports
DOFOLLOW
|
|
CDMO Leadership Awards 2026
http://cdmoleadershipawards.com/
cdmoleadershipawards.com
|
— | 0 | 5 |
(no anchor)
https://csdd.tufts.edu/
DOFOLLOW
|
|
Job openings | Center for Biomedical System Design
https://newdigs.tuftsmedicalcenter.org/about/jobs
newdigs.tuftsmedicalcenter.org
|
41 | 7 | 173 |
CSDD
https://csdd.tufts.edu/
DOFOLLOW
|
|
health outcomes
https://www.highlighthealth.com/tag/health-outcomes
highlighthealth.com
|
14 | 12 | 474 |
Tufts Center for the Study of Drug Development (Tufts CSDD)
http://csdd.tufts.edu/
DOFOLLOW
|
|
Der Preis der Gesundheit | hpd
https://hpd.de/artikel/11952
hpd.de
|
75 | 249 | 2,036 |
Studie des Tufts Center for the Study of Drug Development
http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study
DOFOLLOW
|
|
Fact-Based Health Care Reform - The American Interest
https://www.the-american-interest.com/2017/08/02/fact-based-health-care-reform
the-american-interest.com
|
73 | 466 | 483 |
cost
http://csdd.tufts.edu/files/uploads/CSSD_PhRMAWhitePaper_FINAL.pdf
DOFOLLOW
|
|
Quack Remedy - Econlib
econlib.org
|
79 | 1,095 | 784 |
this report
DOFOLLOW
|
|
Machine Learning Drug Discovery Applications - Pfizer, Roche, GSK, and More
https://emerj.com/machine-learning-drug-discovery-applications-pfizer-roche-gsk
emerj.com
|
66 | 161 | 440 |
average cost
https://csdd.tufts.edu/news/complete_story/tufts_csdd_rd_cost_study_now_published
DOFOLLOW
|
|
CNS Drugs Take Longer to Develop and Have Lower Success Rates than Other Drug...
https://www.appliedclinicaltrialsonline.com/view/cns-drugs-take-longer-develop-and-have-lower-success-rates-other-drugs-according-tufts-center-study
appliedclinicaltrialsonline.com
|
75 | 146 | 25 |
November/December Tufts CSDD Impact Report
http://csdd.tufts.edu/reports/impact_reports
NOFOLLOW
|
|
How Trially.ai Solves the Patient Recruitment Paradox Defined by Tufts Center...
trially.ai
|
12 | 2 | 35 |
Ken Getz
DOFOLLOW
|
|
R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study F...
https://www.kuer.org/2017-09-11/r-d-costs-for-cancer-drugs-are-likely-much-less-than-industry-claims-study-finds
kuer.org
|
75 | 256 | 3,730 |
Joseph DiMasi
http://csdd.tufts.edu/about/staff_profile/joe_dimasi
DOFOLLOW
|
|
R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study F...
https://www.kuer.org/2017-09-11/r-d-costs-for-cancer-drugs-are-likely-much-less-than-industry-claims-study-finds
kuer.org
|
75 | 256 | 3,730 |
Center for the Study of Drug Development Research
http://csdd.tufts.edu/
DOFOLLOW
|
|
Might The Experimental Drug Remdesivir Work Against COVID-19? | South Carolin...
https://www.southcarolinapublicradio.org/2020-03-21/might-the-experimental-drug-remdesivir-work-against-covid-19
southcarolinapublicradio.org
|
70 | 119 | 3,102 |
Ken Kaitin
https://csdd.tufts.edu/csddstaff
DOFOLLOW
|
|
Supreme Court’s IP ruling encourages innovation
https://policyoptions.irpp.org/fr/2017/07/supreme-courts-ip-ruling-encourages-innovation
policyoptions.irpp.org
|
76 | 423 | 2,283 |
new discovery
https://csdd.tufts.edu/files/uploads/Tufts_CSDD_briefing_on_RD_cost_study_-_Nov_18,_2014..pdf
DOFOLLOW
|
|
Supreme Court’s IP ruling encourages innovation
https://policyoptions.irpp.org/fr/2017/07/supreme-courts-ip-ruling-encourages-innovation
policyoptions.irpp.org
|
76 | 423 | 2,283 |
new discovery
https://csdd.tufts.edu/files/uploads/Tufts_CSDD_briefing_on_RD_cost_study_-_Nov_18,_2014..pdf
DOFOLLOW
|
|
Written Statement of Oren Cohen, MD, Senior Vice President and Global Head, E...
https://www.appliedclinicaltrialsonline.com/view/written-statement-oren-cohen-md-senior-vice-president-and-global-head-early-clinical-development-qui
appliedclinicaltrialsonline.com
|
75 | 146 | 25 |
http://csdd.tufts.edu/files/uploads/Outlook-2013.pdf
http://csdd.tufts.edu/files/uploads/Outlook-2013.pdf
NOFOLLOW
|
|
How Trump's FDA Pick Will Shred the Healthcare Safety Net
https://www.vice.com/en/article/how-trumps-fda-pick-will-shred-the-healthcare-safety-net
vice.com
|
86 | 10,501 | 10,757 |
$2.5 billion
http://csdd.tufts.edu/news/complete_story/tufts_csdd_rd_cost_study_now_published
DOFOLLOW
|
|
Functional Service Provider (FSP) Models for Clinical Trials | Clinovo
https://clinovo.com/functional-service-provider-fsp-models
clinovo.com
|
12 | 3 | 1 |
https://csdd.tufts.edu/publications/impact-reports
https://csdd.tufts.edu/publications/impact-reports
NOFOLLOW
|
|
Generative AI in the pharmaceutical industry | McKinsey
https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality?ref=feedtheai.com
mckinsey.com
|
88 | 21,368 | 851 |
Tufts Center for the Study of Drug Development
https://csdd.tufts.edu/
DOFOLLOW
|
|
Clinical Trials: Over Before They Even Begin
https://resources.lifelinksystems.com/clinical-trials-over-before-they-even-begin
resources.lifelinksystems.com
|
7 | 1 | 135 |
has increased 86% over the last 20 years
https://csdd.tufts.edu/csddnews/2018/7/12/press-release-julyaugust-2018-tufts-csdd-impact-report-just-released
DOFOLLOW
|
|
Balancing Innovation and Clinical Trial Efficiency - Is there a Middle Ground? -
https://thejournalofmhealth.com/balancing-innovation-and-clinical-trial-efficiency-is-there-a-middle-ground
thejournalofmhealth.com
|
60 | 52 | 779 |
https://csdd.tufts.edu/white-papers
https://csdd.tufts.edu/white-papers
DOFOLLOW
|
|
Health Experts: Joe Biden's Cancer 'Moonshot' Initiative Overlooks Prevention...
https://www.newsmax.com/newsfront/biden-cancer-moonshot-overlooks/2016/03/21/id/720148
newsmax.com
|
82 | 2,307 | 1,785 |
Tuft University report
http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study
DOFOLLOW
|
|
HealthPad | cancer research
http://www.healthpad.net/tag/322/cancer-research
healthpad.net
|
9 | 3 | 668 |
Tufts Center for the Study of Drug Development
https://csdd.tufts.edu/
DOFOLLOW
|
|
Better Decisions Require More Affordable Treatments: part 2. | EBMLive
https://ebmlive.org/better-decisions-require-more-affordable-treatments-part-2
ebmlive.org
|
9 | 4 | 192 |
development of a newly approved drug
http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study
DOFOLLOW
|
|
Module 2: Clinical Trial Phases & When Things Go Wrong - Clinical Concepts in...
pharmrepclinic.com
|
— | 0 | 11 |
https://csdd.tufts.edu
https://csdd.tufts.edu/
DOFOLLOW
|
|
Generative AI in the pharmaceutical industry | McKinsey
https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality?_hsenc=p2ANqtz-8PfKHAHp98rI78AZ61E_B_6i9L3cR7mfn7J1s3IuV9Piouq9PQ9P0DNf3HKNkxJ75skGxE&utm_campaign=The Batch&utm_medium=email&utm_source=hs_email
mckinsey.com
|
88 | 21,368 | 851 |
Tufts Center for the Study of Drug Development
https://csdd.tufts.edu/
DOFOLLOW
|
|
The Sponsor Oversight Trifecta: Budget Intelligence, Risk-Based Monitoring, a...
https://clinovo.com/resources/blog/the-sponsor-oversight-trifecta-budget-intelligence-risk-based-monitoring-and-strategic-review-for-2026
clinovo.com
|
12 | 3 | 1 |
Tufts Center for the Study of Drug Development
https://csdd.tufts.edu/sites/default/files/2025-02/Aug2024%20Day%20of%20Delay%20White%20Paper%20Final.pdf?1764094586
DOFOLLOW
|
|
Debunking Digital Patient Recruitment Myths for Clinical Trials: Myth #1 - Su...
https://subjectwell.com/patient-recruitment-myths-clinical-trials-1
subjectwell.com
|
13 | 9 | 113 |
Tufts University
http://csdd.tufts.edu/files/uploads/jan-feb_2013_ir_summary.pdf
DOFOLLOW
|
|
New Reports on FDA Drug Approval Performance Emerge as House Committee Consid...
https://www.thefdalawblog.com/2012/05/new-reports-on-fda-drug-approval-performance-emerge-as-house-committee-considers-user-fee-reauthoriz
thefdalawblog.com
|
16 | 29 | 347 |
press release
http://csdd.tufts.edu/files/uploads/may_9,_2012_-_pdufa_v.pdf
DOFOLLOW
|
|
Tufs Study: Cancer Drugs Now Account for 27% of all New Drug Approvals
https://hitconsultant.net/2019/09/03/tufs-study-cancer-drugs-now-account-for-27-of-all-new-drug-approvals
hitconsultant.net
|
76 | 361 | 1,600 |
Tufts Center for the Study of Drug Development
https://csdd.tufts.edu/
DOFOLLOW
|
|
Tufs Study: Cancer Drugs Now Account for 27% of all New Drug Approvals
https://hitconsultant.net/2019/09/03/tufs-study-cancer-drugs-now-account-for-27-of-all-new-drug-approvals
hitconsultant.net
|
76 | 361 | 1,600 |
September/October Tufts CSDD Impact Report,
https://csdd.tufts.edu/impact-reports
DOFOLLOW
|
|
Sponsor-Investigator Relationships: A Crisis of Trust in Life Sciences | Appl...
https://www.appliedclinicaltrialsonline.com/view/sponsor-investigator-relationships-crisis-trust-life-sciences
appliedclinicaltrialsonline.com
|
75 | 146 | 25 |
http://csdd.tufts.edu/files/uploads/02_-_jan_15,_2013_-_recruitment-retention.pdf
http://csdd.tufts.edu/files/uploads/02_-_jan_15,_2013_-_recruitment-retention.pdf
NOFOLLOW
|
|
How Big Pharma Was Captured by the One Percent | The New RepublicThe New Repu...
https://newrepublic.com/article/149438/big-pharma-captured-one-percent
newrepublic.com
|
83 | 3,998 | 106 |
Center for
the Study of Drug Development
https://csdd.tufts.edu/
NOFOLLOW
|
|
Biologically Enhanced Real-World Data: A Winning Formula for Drug Development...
https://www.rdworldonline.com/biologically-enhanced-real-world-data-a-winning-formula-for-drug-development
rdworldonline.com
|
73 | 153 | 1,044 |
http://csdd.tufts.edu/files/uploads/Tufts_CSDD_briefing_on_RD_cost_study_-_Nov_18,_2014..pdf
http://csdd.tufts.edu/files/uploads/Tufts_CSDD_briefing_on_RD_cost_study_-_Nov_18,_2014..pdf
DOFOLLOW
|
|
Pharmaceutical Development - All You Need To Know | Rondaxe
https://www.rondaxe.com/pharmaceutical-drug-development/all-you-need-to-know
rondaxe.com
|
12 | 6 | 4 |
Tufts Center
https://csdd.tufts.edu/
DOFOLLOW
|
|
Back to (Communication) Basics: Reducing Site Burden and Establishing a Spons...
https://globalforum.diaglobal.org/issue/june-2024/back-to-communication-basics-reducing-site-burden-and-establishing-a-sponsor-cro-of-choice-relationship-with-investigative-sites
globalforum.diaglobal.org
|
66 | 31 | 396 |
CSDD website
https://csdd.tufts.edu/white-papers
DOFOLLOW
|
|
HealthPad | cancer care
healthpad.net
|
9 | 3 | 668 |
Tufts Center for the Study of Drug Development
https://csdd.tufts.edu/
DOFOLLOW
|
|
Hospitals Can Teach Life Science Companies a Thing or Two About Patient Engag...
https://hitconsultant.net/2021/06/28/hospitals-life-sciences-patient-engagement-lessons
hitconsultant.net
|
76 | 361 | 1,600 |
increased 86%
https://csdd.tufts.edu/csddnews/2018/7/12/press-release-julyaugust-2018-tufts-csdd-impact-report-just-released
DOFOLLOW
|
|
Event: 2021 Libations for Preservation (at Sea!) | Boston Preservation Alliance
http://bostonpreservation.org/libations/2021
bostonpreservation.org
|
16 | 22 | 615 |
Kenneth Getz
https://csdd.tufts.edu/tufts-csdd-team
DOFOLLOW
|
|
The Record-Time FDA Approval that Almost Didn’t Happen. | Human Events | huma...
humanevents.com
|
77 | 735 | 430 |
$2.5 billion
http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study
DOFOLLOW
|
|
The principal investigator landscape remains a challenge for clinical trial s...
https://davitaclinicalresearch.com/blog/principal-investigator-landscape-remains-challenge-clinical-trial-sponsors
davitaclinicalresearch.com
|
12 | 7 | 41 |
http://csdd.tufts.edu/files/uploads/summaryjan-feb09.pdf
http://csdd.tufts.edu/files/uploads/summaryjan-feb09.pdf
DOFOLLOW
|
|
Steps Toward a Successful Clinical Trial Management System | Applied Clinical...
https://www.appliedclinicaltrialsonline.com/view/steps-toward-successful-clinical-trial-management-system
appliedclinicaltrialsonline.com
|
75 | 146 | 25 |
http://csdd.tufts.edu/files/uploads/tuftscsdd_academic-industry.pdf
http://csdd.tufts.edu/files/uploads/tuftscsdd_academic-industry.pdf
NOFOLLOW
|
|
Understanding Clinical Trial Management System: A Detailed Guide
https://digitalhealth.folio3.com/blog/understanding-clinical-trial-management-system
digitalhealth.folio3.com
|
14 | 16 | 42 |
$1 million to $8 million
https://csdd.tufts.edu/sites/default/files/2025-02/Aug2024%20Day%20of%20Delay%20White%20Paper%20Final.pdf
DOFOLLOW
|
|
Survey of Global Investigative Sites, Provide Your Input Today | Applied Clin...
https://www.appliedclinicaltrialsonline.com/view/survey-global-investigative-sites-provide-your-input-today
appliedclinicaltrialsonline.com
|
75 | 146 | 25 |
Tufts Center for Drug Development
http://csdd.tufts.edu/
NOFOLLOW
|
|
Desde la investigación biomédica a la clínica: avances del Centro Nacional Co...
https://revcmhabana.sld.cu/index.php/rcmh/article/view/191
revcmhabana.sld.cu
|
15 | 16 | 431 |
http://csdd.tufts.edu/files/uploads/how_new_drugs_move.pdf
http://csdd.tufts.edu/files/uploads/how_new_drugs_move.pdf
DOFOLLOW
|
|
FDA Advisory Committee Meetings on Safety of COX-2 Inhibitors Begin - Califor...
http://californiahealthline.org/morning-breakout/fda-advisory-committee-meetings-on-safety-of-cox2-inhibitors-begin
californiahealthline.org
|
73 | 263 | 2,550 |
Tufts Center for the Study of Drug Development
http://csdd.tufts.edu/
DOFOLLOW
|
|
Drug Development Wednesday: What Has Taken So Long? | Gunnar Esiason Blog
gunnaresiason.com
|
9 | 3 | 142 |
$2.4 billion
https://csdd.tufts.edu/
DOFOLLOW
|
|
R&D Spending by Drug Companies – Pharmaceutical Compliance Monitor - Precisio...
https://www.precisionmedicinegrp.com/2016/03/rd-spending-by-drug-companies-pharmaceutical-compliance-monitor
precisionmedicinegrp.com
|
60 | 20 | 63 |
white paper
http://csdd.tufts.edu/files/uploads/PubPrivPaper2015.pdf
DOFOLLOW
|
|
How MassBio Can Help You Achieve ED&I Excellence in Your Workplace - MassBio
https://www.massbio.org/news/recent-news/how-massbio-can-help-you-achieve-edi-excellence-in-your-workplace
massbio.org
|
71 | 66 | 766 |
here
https://csdd.tufts.edu/impact-reports
DOFOLLOW
|
|
How AI and CDMO/CRO Integration is Key to the Future of Drug Development | Co...
https://www.conexiant.com/Oncology/viewarticle?id=a62eb59f-6ed2-4a13-a663-b4b3cdfcb645&pub=The Medicine Maker
conexiant.com
|
71 | 31 | 310 |
113x
https://csdd.tufts.edu/
DOFOLLOW
|
Frequently Asked Questions
How many backlinks does csdd.tufts.edu have?
The backlinks page for csdd.tufts.edu shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on csdd.tufts.edu. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to csdd.tufts.edu dofollow or nofollow?
Backlinks to csdd.tufts.edu include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.